3.58

5.29% -0.20

Exagen Inc (XGN)

Overview News Price History Option Chain Financials Discussions Forecast

Exagen Inc stock is traded at $3.58, with a volume of 54,317. It is down -5.29% in the last 24 hours and down -10.72% over the past month. Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.

Previous Close:

$3.78

Open:

$3.77

24h Volume:

54,317

Relative Volume:

0.31

Market Cap:

$63.14M

Revenue:

$52.55M

Net Income/Loss:

$-23.69M

P/E Ratio:

-3.8085

EPS:

-0.94

Net Cash Flow:

$-15.29M

1W Performance:

-15.37%

1M Performance:

-10.72%

6M Performance:

+16.61%

1Y Performance:

+77.23%

1-Day Range:

$3.52

$3.9611

1-Week Range:

$3.52

$4.36

52-Week Range:

$1.3003

$6.22

Exagen Inc Stock (XGN) Company Profile

Name

Exagen Inc

Sector

Healthcare (1169)

Industry

Diagnostics & Research (60)

Phone

(760) 560-1501

Address

1261 LIBERTY WAY, VISTA, CA

Employee

179

Twitter

@ExagenInc

Next Earnings Date

2024-11-12

Latest SEC Filings

XGN's Discussions on Twitter

Compare XGN with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
XGN Exagen Inc	3.58	63.14M	52.55M	-23.69M	-15.29M	-0.94
TMO Thermo Fisher Scientific Inc	532.55	203.70B	42.88B	6.34B	7.27B	16.53
DHR Danaher Corp	210.23	151.18B	23.88B	3.90B	5.30B	5.28
A Agilent Technologies Inc	135.37	38.62B	6.51B	1.29B	1.37B	4.42
IDXX Idexx Laboratories Inc	452.77	37.07B	3.90B	887.87M	808.08M	10.67
IQV Iqvia Holdings Inc	191.04	33.64B	15.41B	1.37B	2.11B	7.50

Exagen Inc Stock (XGN) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-05-22	Downgrade	KeyBanc Capital Markets	Overweight → Sector Weight
Oct-15-21	Resumed	Cowen	Outperform
Apr-15-21	Initiated	Canaccord Genuity	Buy
Nov-10-20	Initiated	KeyBanc Capital Markets	Overweight
Oct-08-20	Initiated	BTIG Research	Buy
Jun-02-20	Resumed	Cantor Fitzgerald	Overweight
Oct-14-19	Initiated	Cantor Fitzgerald	Overweight
Oct-14-19	Initiated	Cowen	Outperform
Oct-14-19	Initiated	William Blair	Outperform